Canada’s Applied Research in Cancer Control Conference
900 Rue de la Gauchetière O
The Canadian Centre for Applied Research in Cancer Control (ARCC) is pleased to announce that its 7th annual conference will take place from May 27th to 28th at the Hotel Bonaventure in Montréeal, Québec. The objective of this conference is to bridge a connection between researchers and decision-makers, using health economics, services, policy and ethics research to improve cancer control and the delivery of cancer care.
James A. Hanley, PhD (Plenary Panelist)
Please visit http://www.medicine.mcgill.ca/epidemiology/hanley/ for more information!
Jeffrey S. Hoch, PhD (Plenary Moderator)
Bio coming soon!
Visit http://www.ucdmc.ucdavis.edu/publish/providerbio/search/21921 for more information
Marie-Hélène Mayrand, MD, PhD (Plenary Panelist)
Marie-Hélène Mayrand is a professor in the departments of Obstetrics and Gynecology and Social and Preventive Medicine at the Université de Montréal, where she completed her medical degree and specialty training. She completed her PhD in Epidemiology at McGill University, focusing the evaluation of a new cervical cancer-screening test. Her professional work spans clinical, biomedical research and public health aspects of cancer prevention. She practices colposcopy at the CHUM. She has led large multi-center trials focusing on more efficient prevention of cervical cancer through innovative screening/treatment algorithms and vaccination schedules. Dr Mayrand has worked with professional (SOGC, SCC, GOC, CCS) and public health (INESSS, INSPQ, CIQ, CPAC) organizations to draft clinical guidelines, provide government reports/advice, and move public health and clinical practice in line with the best available evidence.
Stay tuned for additional speakers and information!
Abstract submission for the 2018 ARCC Conference is now open! Abstract submission closes Friday February 2nd, 2018.
Abstract submission is free – dont delay, submit your abstract today and join us in Montreal in May 2018
Questions? Contact us at firstname.lastname@example.org
ARCC will again be offering travel support (up to $1000) for students presenting at our conference. To be eligible for a student travel award, the student must be submitting an abstract to and presenting at the 2018 ARCC conference. The application for student travel awards is electronic and will only be available in parallel with abstract submission. If you have any questions, please contact ARCC@cancercare.on.ca
To Apply: When submitting your abstract to the ARCC Conference, you will be asked about student status and have the option to complete the Student Travel Award Application form. Guidelines for the Student travel awards are found in the Abstract Guidelines document which can be viewed by clicking here..
contact ARCC@cancercare.on.ca for more information
The 2018 ARCC Conference will be hosted at the Hotel Bonaventure in Montréal, Québec.
Registration for the 2018 ARCC Conference will open January 19, 2018
Early Bird Registration Rates are in effect from January 19th, 2018 – April 20th, 2018
Early-Bird Member – $100
Early-Bird Non-Member – $200
Early-Bird Student (member) – $50
Early-Bird Student (non-member) – $100
New-Professional* (members only) – $50
Industry – $500
Regular Rates in effect April 21st, 2018
ARCC Members – $150
Non-Member – $300
Student (member) – $75
Student (non-member) – $150
New-Professional* (members only) – $75
Industry – $500
**If you are a new professional (within 5 years of receiving your terminal degree) please email ARCC@cancercare.on.ca for a registration code and receive a special new professional rate!!!
Dr. Kelvin Chan, MD, FRCP, MSc - (ARCC Co-Director)
Dr. Kelvin Chan is a medical oncologist at Sunnybrook Odette Cancer Centre and an Assistant Professor at the University of Toronto. He is also a clinical epidemiologist with a focus in health economics, and a biostatistician. His research interests include health services research, health technology and drug assessments, economic evaluations, systematic review and meta-analysis including network meta-analysis. Professionally, he is interested in drug funding and reimbursement issues. He is a member of Ontario’s Committee to Evaluate Drugs (CED) and the Ontario Steering Committee of Cancer Drugs (OSCCD). He is also the clinical lead of the Provincial Drug Reimbursement Programs (RPDP) at Cancer Care Ontario (CCO).
Dr. Wanrudee Isaranuwatchai, PhD (Conference Co-Chair)
Dr. Wanrudee Isaranuwatchai is a Research Scientist (a health economist) at the Canadian Centre for Applied Research in Cancer Control and at St. Michael’s Hospital. She is also an Assistant Professor at the University of Toronto. Her research focuses on how to apply economic evaluation in the real world setting as well as how to advance methods in economic evaluation. She has experience conducting economic evaluations using person-level data and decision modeling. She has collaborated with researchers and decision-makers in various areas to help communicate the value of health initiatives using economic evidence. Dr. Isaranuwatchai is dedicated to promoting the use of evidence in healthcare decision making.
Dr. Stuart Peacock, PhD - (ARCC Co-Director)
Stuart Peacock holds the Leslie Diamond Chair in Cancer Survivorship and is a Professor in the Faculty of Health Sciences, Simon Fraser University. He is currently Co-Director of the Canadian Centre for Applied Research in Cancer Control (ARCC). ARCC is a pan-Canadian research centre providing interdisciplinary leadership in health economics, services, policy and ethics research. Stuart is also a Distinguished Scientist in Cancer Control Research at the BC Cancer Agency, a member of the Board of Directors of the Canadian Agency for Drugs and Technologies in Health, and past President of the International Society on Priorities in Health Care. He has held university positions in Canada, Australia and the UK. Over the past 20 years, Stuart’s main research interests have focused on research into developing more effective cancer services, making health system funding decisions fairer and more transparent, and improving the quality of life of cancer patients and survivors.
Dr. Erin Strumpf, PhD (Conference Co-Chair)
Erin Strumpf, PhD, is an Associate Professor in the Department of Economics and the Department of Epidemiology, Biostatistics and Occupational Health at McGill University. She is a William Dawson Scholar and holds a Chercheur boursier career award from the Fonds de recherche du Québec – Santé. She received her PhD in Health Policy from Harvard University and her BA from Smith College.
Dr. Strumpf’s research in health economics focuses on evaluating the impacts of health and social policies on the health and wellbeing of individuals and populations, on inequalities across groups, and on the performance of the health care system. She uses administrative health data, large-scale surveys, and methods for causal inference – principally quasi-experimental designs – to estimate the effects of interventions and reforms in real-world settings. Dr. Strumpf and her research team actively collaborate with decision makers to generate relevant, usable knowledge to improve population health and health care system performance. She has presented her work to provincial ministries of health and of finance in Canada, and to policymakers in France and the United States.